Millennium Management
VTGN icon

Millennium Management’s VistaGen Therapeutics VTGN Stock Holding History

Millennium Management’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
430,404
+233,359
+118% +$142K ﹤0.01% 5086
2025
Q4 		$130K Buy
197,045
+176,369
+853% +$637K ﹤0.01% 5582
2025
Q3 		$73.4K Buy
+20,676
New +$61.8K ﹤0.01% 5767
2025
Q1 		– Sell
-38,732
Closed -$114K – 6448
2024
Q4 		$114K Buy
38,732
+13,395
+53% +$37.7K ﹤0.01% 5453
2024
Q3 		$76.3K Buy
+25,337
New +$86.5K ﹤0.01% 5629
2024
Q2 		– Sell
-36,498
Closed -$193K – 6598
2024
Q1 		$193K Buy
+36,498
New +$175K ﹤0.01% 5391
2023
Q4 		– Sell
-16,870
Closed -$88.4K – 6595
2023
Q3 		$88.4K Sell
16,870
-84,200
-83% -$374K ﹤0.01% 5368
2023
Q2 		$189K Buy
+101,070
New +$354K ﹤0.01% 5138
2023
Q1 		– Sell
-3,583
Closed -$11K – 6909
2022
Q4 		$11K Sell
3,583
-24,904
-87% -$93.7K ﹤0.01% 6172
2022
Q3 		$130K Sell
28,487
-612
-2% -$6.07K ﹤0.01% 5866
2022
Q2 		$768K Sell
29,099
-12,244
-30% -$432K ﹤0.01% 4609
2022
Q1 		$1.54M Buy
41,343
+40,990
+11,612% +$1.79M ﹤0.01% 4109
2021
Q4 		$21K Sell
353
-14,492
-98% -$943K ﹤0.01% 6600
2021
Q3 		$1.22M Buy
14,845
+8,955
+152% +$778K ﹤0.01% 4464
2021
Q2 		$557K Sell
5,890
-40,656
-87% -$3.01M ﹤0.01% 5211
2021
Q1 		$2.97M Buy
46,546
+20,490
+79% +$1.37M ﹤0.01% 3143
2020
Q4 		$1.52M Buy
+26,056
New +$665K ﹤0.01% 3445
2019
Q1 		– Sell
-621
Closed -$28K – 4370
2018
Q4 		$28K Buy
+621
New +$33.8K ﹤0.01% 3653

Other funds holding VTGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Millennium Management's VTGN Position: Q1 2026 in Review

Millennium Management increased its VistaGen Therapeutics (VTGN) stake by 118% in Q1 2026, buying an estimated $142K and bringing the position to 430,404 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #5086.

Millennium Management first reported a position in VTGN in Q4 2018 and has held it in 18 quarters since. The position peaked at $2.97M in Q1 2021. 56 funds tracked by Wall St. Rank hold VTGN as of Q1 2026.

  • Millennium Management held 430,404 shares of VistaGen Therapeutics worth $246K as of Q1 2026.
  • Millennium Management bought 233,359 VistaGen Therapeutics shares in Q1 2026, an estimated $142K.
  • VistaGen Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5086 holding.
  • Millennium Management first reported a position in VistaGen Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • Millennium Management's VistaGen Therapeutics position peaked at $2.97M in Q1 2021.
  • 56 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.